dr. Lynda Grine

ORCID iD: 0000-0002-7546-4454

Show Sort by

Add to list
- Journal Article
- A1
Image analysis systems to calculate the surface area of vitiligo lesions : a systematic review of measurement properties

Nanja van Geel (UGent) , Imke Saeys, Jérôme Van Causenbroeck, Jolien Duponselle (UGent) , Lynda Grine (UGent) , Nele Pauwels (UGent) , Niels Hilhorst (UGent) , Sandrine Herbelet (UGent) , Khaled Ezzedine and Reinhart Speeckaert (UGent)

(2022) PIGMENT CELL & MELANOMA RESEARCH. 35(5). p.480-494
Add to list
- Journal Article
- A1
- open access
Promising tools to facilitate the implementation of TDM of biologics in clinical practice

Rani Soenen (UGent) , Christophe Stove (UGent) , Alessio Capobianco, Hanne De Schutter, Marie Dobbelaere, Tahmina Mahjor, Merel Follens, Jo Lambert (UGent) and Lynda Grine (UGent)

(2022) JOURNAL OF CLINICAL MEDICINE. 11(11).
Add to list
- Journal Article
- A1
Patient-relevant outcomes in psoriasis : a systematic review

Niels Hilhorst (UGent) , Elfie Deprez (UGent) , Nele Pauwels (UGent) , Lynda Grine (UGent) , Jo Lambert (UGent) and Isabelle Hoorens (UGent)

(2022) JAMA DERMATOLOGY. 158(7). p.806-811
Add to list
- Conference Paper
- C3
The effects of Modified Intermittent Fasting in Psoriasis (MANGO) : preliminary results of a pilot crossover study

Lynda Grine (UGent) , Niels Hilhorst (UGent) , Fien Strobbe, Raquel Van Den Eynde, Elien Geerits, Emma Coppenolle, Nathalie Michels (UGent) , Souheila Abbeddou (UGent) , Stefaan De Henauw (UGent) and Jo Lambert (UGent)

(2022) BRITISH JOURNAL OF DERMATOLOGY. In British Journal of Dermatology 186(1). p.E22-E22
Add to list
- Journal Article
- A1
- open access
Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis

Rani Soenen (UGent) , Zhigang Wang, Lynda Grine (UGent) , Erwin Dreesen, Lisa Schots (UGent) , Els Brouwers, Paul Declerck, Debby Thomas and Jo Lambert (UGent)

(2022) CLINICAL AND EXPERIMENTAL DERMATOLOGY. 47(7). p.1324-1336
Add to list
- Journal Article
- A1
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey

Lisa Schots (UGent) , Lynda Grine (UGent) , Rani Soenen (UGent) and Jo Lambert (UGent)

(2022) JOURNAL OF DERMATOLOGICAL TREATMENT. 33(3). p.1473-1481
Add to list
- Journal Article
- A2
- open access
The effects of Modified Intermittent Fasting in Psoriasis (MANGO) trial : a two-arm pilot randomized controlled open cross-over study

Lynda Grine (UGent) , Niels Hilhorst (UGent) , Nathalie Michels (UGent) , Souheila Abbedou, Stefaan De Henauw (UGent) and Jo Lambert (UGent)

(2022) JMIR RESEARCH PROTOCOLS. 11(2).
Add to list
- Journal Article
- A1
- open access
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis : study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study : the BeNeBio study

Lara S. van der Schoot, Juul M. P. A. van den Reek, Lynda Grine (UGent) , Lisa Schots (UGent) , Wietske Kievit, Jo Lambert (UGent) and Elke M. G. J. de Jong

(2021) TRIALS. 22(1).
Add to list
- Conference Paper
- C3
Interim results of the MANGO trial : modified intermittent fasting in psoriasis

Lynda Grine (UGent) , Niels Hilhorst (UGent) , Nathalie Michels (UGent) , Souheila Abbeddou (UGent) , Stefaan De Henauw (UGent) and Jo Lambert (UGent)

(2021) JOURNAL OF INVESTIGATIVE DERMATOLOGY. In Journal of Investigative Dermatology 141(10). p.S190-S190
Add to list
- Journal Article
- A2
- open access
Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study

Pierre-Dominique Ghislain, Valérie Failla, Jo Lambert (UGent) , Rani Soenen (UGent) , Lynda Grine (UGent) , Julio Tannous, Françoise Guiot, Fabienne Willaert, Hugues Fierens, Mark Vandaele, et al.

(2021) JAAD INTERNATIONAL. 4. p.15-17
Add to list
- Journal Article
- A1
- open access
Gut-skin axis : current knowledge of the interrelationship between microbial dysbiosis and skin conditions

Britta De Pessemier (UGent) , Lynda Grine (UGent) , Melanie Debaere, Aglaya Maes, Bernhard Paetzold and Chris Callewaert (UGent)

(2021) MICROORGANISMS. 9(2).
Add to list
- Journal Article
- A1
- open access
Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES)

Nanja van Geel (UGent) , S. E. Uitentuis, M. Zuidgeest, A. Wolkerstorfer, M. W. Bekkenk, C. Moock, C. Van Goethem, E. Verlaeckt, C. Smet, Lynda Grine (UGent) , et al.

(2021) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 35(1). p.216-221
Add to list
- Journal Article
- A1
- open access
The implementation of a structured specialized consultation for psoriasis management

Jo Lambert (UGent) , ANA ALVES DE MEDEIROS (UGent) , Astrid Van Reempts (UGent) , Kim Van Langenhove, Judith Rossey, Elfie Deprez (UGent) , Lucia Van Poucke (UGent) and Lynda Grine (UGent)

(2021) ACTA CLINICA BELGICA. 76(6). p.421-426
Add to list
- Journal Article
- A1
- open access
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Nathalie Van den Berghe, Aurélie Truffot, Miet Peeters, Griet Compernolle, Els Brouwers, Rani Soenen (UGent) , Lynda Grine (UGent) , Ann Gils and Maya Imbrechts

(2020) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 189.
Add to list
- Journal Article
- A1
- open access
Improving patient involvement in the lifecycle of medicines : insights from the EUPATI BE survey

Lynda Grine (UGent) , Rosanne Janssens, Eline van Overbeeke, Danielle Derijcke, Mitchell Silva, Belinda Delys, Isabelle Dusart, Veerle Aertsen, Magali Mertens de Wilmars, Joanna Robaczewska, et al.

(2020) FRONTIERS IN MEDICINE. 7(36).
Add to list
- Journal Article
- A1
Comparison of personality traits among patients with psoriasis, atopic dermatitis, and stress: a pilot study

Lynda Grine (UGent) , Giulia Tochtermann, Hilde Lapeere, Nele Maes (UGent) , Günther F. L. Hofbauer, Myriam Vervaet (UGent) and Jo Lambert (UGent)

(2020) DERMATOLOGY. 236(4). p.324-328
Add to list
- Journal Article
- A1
Standardizing serial photography for assessing and monitoring vitiligo : a core set of international recommendations for essential clinical and technical specifications

Nanja van Geel (UGent) , Iltefat Hamzavi, Indermeet Kohli, Albert Wolkerstorfer, Henry W. Lim, Jung Min Bae, Harvey Lui, John E. Harris, Amit G. Pandya, Steven Thng Tien Guan, et al.

(2020) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 83(6). p.1639-1646
Add to list
- Journal Article
- A1
- open access
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management

Lynda Grine (UGent) , Michel de la Brassinne, Pierre‐Dominique Ghislain, Tom Hillary, Julien Lambert, Siegfried Segaert, Fabienne Willaert, Jo Lambert (UGent) , Farida Benhadou, Chantal Bonardeaux, et al.

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(4). p.676-684
Add to list
- Journal Article
- A1
- open access
Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert (UGent) , Sven Lanssens, Linda Temmerman, Jo Lambert (UGent) and Ann Gils

(2019) JOURNAL OF INVESTIGATIVE DERMATOLOGY. 139(10). p.2232-2235
Add to list
- Journal Article
- A1
Therapeutische Patientenschulungsprogramme und Unterstützung beim Selbstmanagement für Patienten mit Psoriasis : eine systematische Übersicht

Corinna Dressler, Jo Lambert (UGent) , Lynda Grine (UGent) , Paul Galdas, Carle Paul, Miriam Zidane and Alexander Nast

(2019) JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 17(7). p.685-697
Add to list
- Journal Article
- A2
Therapeutic patient education and self‐management support for patients with psoriasis : a systematic review

Corinna Dressler, Jo Lambert (UGent) , Lynda Grine (UGent) , Paul Galdas, Carle Paul, Miriam Zidane and Alexander Nast

(2019) JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 17(7). p.685-695
Add to list
- Journal Article
- A1
Clinical visible signs of disease activity in vitiligo : a systematic review and meta‐analysis

Nanja van Geel (UGent) , Lynda Grine (UGent) , Pauline de Wispelaere (UGent) , D Mertens, CAC Prinsen and Reinhart Speeckaert (UGent)

(2019) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 33(9). p.1667-1675
Add to list
- Conference Paper
- C3
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Linda Temmerman (UGent) , Sven Lanssens, Els Brouwers, Nathalie Van den Berghe, Reinhart Speeckaert (UGent) , Jo Lambert (UGent) and Ann Gils

(2019) 24th World Congress of Dermatology, Abstracts.
Add to list
- Journal Article
- A1
Reference method for digital surface measurement of target lesions in vitiligo : a comparative analysis

Nanja van Geel (UGent) , D Vandendriessche, E Vandersichel, S De Schepper, Lynda Grine (UGent) , L Mertens, V Vandaele, F Spoelders, M Bekkenk, A Wolkerstorfer, et al.

(2019) BRITISH JOURNAL OF DERMATOLOGY. 180(5). p.1198-1205
Add to list
- Conference Paper
- C3
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter, Lynda Grine (UGent) , Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert (UGent) , Sven Lanssens, Linda Temmerman (UGent) , Jo Lambert (UGent) and Ann Gils

(2018) Skin Immune Mediated Inflammatory Diseases, 2nd European workshop, Abstracts.
Add to list
- Journal Article
- A1
Targeting the IL-23/IL-17 pathway in psoriasis : the search for the good, the bad and the ugly

Sofie Mylle, Lynda Grine (UGent) , Reinhart Speeckaert (UGent) , Jo Lambert (UGent) and Nanja van Geel (UGent)

(2018) AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 19(5). p.625-637
Add to list
- Journal Article
- A1
Towards the development of a RNAi-based topical treatment for psoriasis : proof-of-concept in a 3D psoriasis skin model

Eline Desmet, Mireille Van Gele (UGent) , Lynda Grine (UGent) , Katrien Remaut (UGent) and Jo Lambert (UGent)

(2018) EXPERIMENTAL DERMATOLOGY. 27(5). p.463-469
Add to list
- Miscellaneous
Dienst Dermatologie UZ Gent wordt beloond voor inzet in de zorg voor psoriasis

Lynda Grine (UGent) , Ana Alves de Medeiros (UGent) , Nele Maes, Elfie Deprez, Lucia Van Poucke and Jo Lambert (UGent)

(2017) CUTIS CURA. 4(1). p.3-4
Add to list
- Miscellaneous
Laat wat van je horen

Lynda Grine (UGent) and Jo Lambert (UGent)

(2017) PSORIANT. 34(4). p.11-11
Add to list
- Miscellaneous
Je hebt psoriasis... maar ken je psoriasis?

Lynda Grine (UGent) and Jo Lambert (UGent)

(2016) PSORIANT. 34(3). p.14-15
Add to list
- Journal Article
- A1
Analysis of telomere length as predictive marker in psoriasis for comorbidities

Emma Coussens, Lynda Grine (UGent) , JESSICA BOSTOEN (UGent) , Herman Mielants (UGent) and Jo Lambert (UGent)

(2016) EXPERIMENTAL DERMATOLOGY. 25(5). p.388-390
Add to list
- Journal Article
- A1
- open access
Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice'

Lynda Grine (UGent) , Claude Libert (UGent) and Roosmarijn Vandenbroucke (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 174(6). p.1419-1419
Add to list
- Conference Paper
- C3
Global survey into the use of therapeutic patient education during psoriasis management

Lynda Grine (UGent) , Jo Lambert (UGent) , C Paul and A Nast

(2016) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 30(suppl. 6). p.64-64
Add to list
- Miscellaneous
Psoriasis : burning down the host

Lynda Grine (UGent) and Jo Lambert (UGent)

(2016) JOURNAL OF DERMATOLOGICAL TREATMENT. 27(1). p.1-1
Add to list
- Journal Article
- A1
The many faces of interleukin-17 in inflammatory skin diseases

Reinhart Speeckaert (UGent) , Jo Lambert (UGent) , Lynda Grine (UGent) , Mireille Van Gele (UGent) , Sofie De Schepper (UGent) and Nanja van Geel (UGent)

(2016) BRITISH JOURNAL OF DERMATOLOGY. 175(5). p.892-901
Add to list
- Journal Article
- A1
- open access
Topical imiquimod yields systemic effects due to unintended oral uptake

Lynda Grine (UGent) , Sophie Steeland (UGent) , Sara Van Ryckeghem (UGent) , Marlies Ballegeer (UGent) , Stefan Lienenklaus, Siegfried Weiss, Niek Sanders (UGent) , Roosmarijn Vandenbroucke (UGent) and Claude Libert (UGent)

(2016) SCIENTIFIC REPORTS. 6.
Add to list
- Miscellaneous
microRNAs in psoriasis: leaders or followers?

Jo Lambert (UGent) , Lynda Grine (UGent) and Mireille Van Gele (UGent)

(2015) BRITISH JOURNAL OF DERMATOLOGY. 173(2). p.323-323
Add to list
- Journal Article
- A1
Dual inhibition of TNFR1 and IFNAR1 in imiquimod-induced psoriasiform skin inflammation in mice

Lynda Grine (UGent) , Lien Dejager (UGent) , Claude Libert (UGent) and Roosmarijn Vandenbroucke (UGent)

(2015) JOURNAL OF IMMUNOLOGY. 194(11). p.5094-5102
Add to list
- Journal Article
- A1
An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17

Lynda Grine (UGent) , Lien Dejager (UGent) , Claude Libert (UGent) and Roosmarijn Vandenbroucke (UGent)

(2015) CYTOKINE & GROWTH FACTOR REVIEWS. 26(1). p.25-33
Add to list
- Journal Article
- A1
TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction

Filip Van Hauwermeiren (UGent) , Roosmarijn Vandenbroucke (UGent) , Lynda Grine (UGent) , Sofie Lodens, Elien Van Wonterghem (UGent) , Riet De Rycke (UGent) , N De Geest, B Hassan and Claude Libert (UGent)

(2015) MUCOSAL IMMUNOLOGY. 8(4). p.828-840
Add to list
- PhD Thesis
- open access
Study of the role of type I interferons in TNF-mediated inflammation

Lynda Grine (UGent)

(2014)
Add to list
- Journal Article
- A1
Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models

Filip Van Hauwermeiren (UGent) , Roosmarijn Vandenbroucke (UGent) , Lynda Grine (UGent) , Leen Puimège (UGent) , Elien Van Wonterghem (UGent) , Hong Zhang and Claude Libert (UGent)

(2014) INTERNATIONAL JOURNAL OF CANCER. 135(3). p.742-750

Image analysis systems to calculate the surface area of vitiligo lesions : a systematic review of measurement properties

Promising tools to facilitate the implementation of TDM of biologics in clinical practice

Patient-relevant outcomes in psoriasis : a systematic review

The effects of Modified Intermittent Fasting in Psoriasis (MANGO) : preliminary results of a pilot crossover study

Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis

Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey

The effects of Modified Intermittent Fasting in Psoriasis (MANGO) trial : a two-arm pilot randomized controlled open cross-over study

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis : study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study : the BeNeBio study

Interim results of the MANGO trial : modified intermittent fasting in psoriasis

Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study

Gut-skin axis : current knowledge of the interrelationship between microbial dysbiosis and skin conditions

Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES)

The implementation of a structured specialized consultation for psoriasis management

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Improving patient involvement in the lifecycle of medicines : insights from the EUPATI BE survey

Comparison of personality traits among patients with psoriasis, atopic dermatitis, and stress: a pilot study

Standardizing serial photography for assessing and monitoring vitiligo : a core set of international recommendations for essential clinical and technical specifications

A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management

Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy

Therapeutische Patientenschulungsprogramme und Unterstützung beim Selbstmanagement für Patienten mit Psoriasis : eine systematische Übersicht

Therapeutic patient education and self‐management support for patients with psoriasis : a systematic review

Clinical visible signs of disease activity in vitiligo : a systematic review and meta‐analysis

Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Reference method for digital surface measurement of target lesions in vitiligo : a comparative analysis

Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Targeting the IL-23/IL-17 pathway in psoriasis : the search for the good, the bad and the ugly

Towards the development of a RNAi-based topical treatment for psoriasis : proof-of-concept in a 3D psoriasis skin model

Dienst Dermatologie UZ Gent wordt beloond voor inzet in de zorg voor psoriasis

Laat wat van je horen

Je hebt psoriasis... maar ken je psoriasis?

Analysis of telomere length as predictive marker in psoriasis for comorbidities

Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice'

Global survey into the use of therapeutic patient education during psoriasis management

Psoriasis : burning down the host

The many faces of interleukin-17 in inflammatory skin diseases

Topical imiquimod yields systemic effects due to unintended oral uptake

microRNAs in psoriasis: leaders or followers?

Dual inhibition of TNFR1 and IFNAR1 in imiquimod-induced psoriasiform skin inflammation in mice

An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17

TNFR1-induced lethal inflammation is mediated by goblet and Paneth cell dysfunction

Study of the role of type I interferons in TNF-mediated inflammation

Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models